Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform
Posted on: Thursday, 25 June 2009, 09:38 CDT
Mr. Steele is speaking about NeoStrata Company, Inc., and the submission of their findings from a recent clinical study announcing the significant cost-savings associated with their non-prescription, psoriasis medicine PSORENT(R) psoriasis topical solution.
Earlier this week, NeoStrata Company, Inc. submitted results for publication from an 18 week long clinical study demonstrating how psoriasis patients can save hundreds of dollars a year with their novel, non-prescription psoriasis therapy that has outperformed the leading non-steroidal prescription topical in treating the redness and scaling of psoriasis.
"In these economic times we are thrilled to be able to offer a psoriasis medicine that does not require a prescription, is significantly less expensive than most prescription drugs for psoriasis, and performs as well or better than a leading prescription medication," says Mr. Steele.
"This is not a story you hear very often, and as a small company," he explains, "we are just very excited and proud of this new psoriasis therapy and of the value it presents to patients."
NeoStrata Company, Inc. has spent the last few years developing PSORENT(R) and conducting clinical studies and after just receiving the cost savings analyses agrees the timing couldn't be better in tune with what's happening in the economy.
"As a small company," Steele explains, "we have created an affordable and preferable treatment for psoriasis that can save patients hundreds and thousands of dollars in healthcare costs, and we want you to know that we are with you, Mr. President."
About PSORENT(R)
PSORENT(R) is a new topical solution that has the proven efficacy of a prescription medication but is available as an OTC. This aesthetically advanced, quick-drying solution is highly effective, easy and pleasant to use, and has a patient satisfaction rating of nearly 90%.
About NeoStrata
NeoStrata Company, Inc., located in
More information is available at www.neostrata.com and www.psorent.com.
SOURCE NeoStrata Company, Inc.
Source: PR Newswire
Related Articles
- Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers
- COPAXONE(R) Demonstrated Protective Effect in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
- Dairyland Healthcare Solutions' Clinical Information Systems Receives CCHIT Certification
- Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies With REOLYSIN(R)
- Patient Portal Technologies to Launch MedEx Home Delivery; Pilot Program to Offer Free Prescription Delivery to Patients Discharged From Hospital
- FDA Approves REMICADE(R) for Treatment of Chronic Severe Plaque Psoriasis: Marks Major Milestone for Patients With High Disease Burden
- Research and Markets: 'Metabolomics' is Especially Suited to the Screening of Patients for Clinical Trials
- Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture Results*
- Quality-of-Life Determinants in Patients With Clinically Stable Bronchiectasis*
- U. Enlists Patients in Clinical Study Linked to Fatal Lung Disease
 |
 |
User Comments (0)
RSS Feeds